Eilidh Bedford

Eilidh Bedford serves as the Chief Technology Officer for Cytiva Bioprocess at Danaher Corporation, focusing on improving access to biological drugs. With extensive experience in technology leadership, Eilidh previously held roles such as Interim Chief Technology Officer for the Biotechnology Group, Chief Technology Officer at Pall Corporation, and Vice President of R&D in Materials Science. Eilidh's career includes significant contributions at Harvard University as an Advisory Board Member, and leadership positions in R&D at Cabot Corporation, Living Proof, Johnson & Johnson, and Unilever, where a wide range of innovations in materials science and product development were achieved. Eilidh holds a PhD in Natural Sciences specializing in Materials Science from the University of Cambridge.